【】Late-onset Alzheimer’s disease

23andMe is already telling curious customers everywhere they're descended from, but the genetics service has finally received permission to provide a little more information based on DNA samples.。
23andMe now has approval from the Food and Drug Administration to tell its users if they're at a higher risk of some diseases based on their DNA. 。
That's what the startup tried to do originally, before it was forced to shut down that service since it didn't have FDA approval to provide actual medical knowledge based on its genetic testing. Now, the service is allowed to tell users if they're at risk for 10 diseases: 。
Thanks for signing up!。
Parkinson’s disease。
Late-onset Alzheimer’s disease。
Celiac disease 。
Alpha-1 antitrypsin deficiency, a disorder that raises the risk of lung and liver disease;
Early-onset primary dystonia, a movement disorder involving involuntary muscle contractions and other uncontrolled movements。
Factor XI deficiency, a blood clotting disorder 。
Factor XI deficiency, a blood clotting disorder。
Gaucher disease type 1, an organ and tissue disorder。
Glucose-6-Phosphate Dehydrogenase deficiency, also known as G6PD, a red blood cell condition。
Hereditary hemochromatosis, an iron overload disorder 。

Hereditary thrombophilia, a blood clot disorder。 The FDA noted in its announcement that this is the first approved use of direct-to-consumer tests for genetic risks. The information provided by 23andMe won't involve actual diagnoses of diseases — only the genetic risk of having them. 。 As。
As。
Vox 。
pointed out, before 23andMe hit some major stumbling blocks with its medical plans in 2013, the startup wanted to provide information about a lot more than 10 diseases. At one point, 23andMe planned to determine risks for 254 health conditions. 。
As of late, 23andMe has provided some basic health information to its customers, but only in categories that aren't subject to the same kind of regulation: lactose intolerance, genetic weight and alcohol flush reaction, among others. 。
Now the FDA is open to some uses of direct-to-consumer besides heritage breakdowns. Although 23andMe can still do that. 。
Now the FDA is open to some uses of direct-to-consumer besides heritage breakdowns. Although 23andMe can still do that.。Tweet may have been deleted 。Featured Video For You 。This company is microchipping its workers to give them an all-access pass to the office 。
相关文章
Slack goes down again, prompting anxiety everywhere
Panic briefly took over on Tuesday when everyone's favorite messaging app/millstone went down tempor2025-09-14Tim Cook once scolded Uber's Travis Kalanick into submission
Travis Kalanick, Silicon Valley's bad。 boy 。 CEO, once had a very uncomfortable confrontation with Ap2025-09-14- A new streetwear brand is focused on making apparel with a purpose, helping at-risk youth not only r2025-09-14
We read Ivanka Trump's insufferable new book so you don't have to
As you may have heard, First Daughter Ivanka Trump released her second book Tuesday, called Women Wh2025-09-14Hiddleswift finally followed each other on Instagram after 3 excruciating days
On Aug. 13, 1961, Germany began construction of the Berlin Wall, perhaps the greatest symbol of the2025-09-14Kendall Jenner appeared on the cover of Vogue India and people had a LOT to say
So, Kendall Jenner appears on the May issue of 。 Vogue India 。 to celebratethe magazine's 10th anniver2025-09-14
最新评论